The impact of combined oral contraceptives on ocular tissues: a review of ocular effects [PDF]
International Journal of Ophthalmology, 2017 The aim of this manuscript is to review the action and adverse effects of combined oral contraceptives (COCs) on ocular tissues. The percentage of unwanted pregnancies and the subsequent abortions make contraception crucial worldwide.
Marilita M. Moschos, Eirini Nitoda
doaj +2 more sources
Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases [PDF]
British medical journal, 2015 Objective To investigate the association between use of combined oral contraceptives and risk of venous thromboembolism, taking the type of progestogen into account. Design Two nested case-control studies.
Coupland, C. +2 more
core +4 more sources
Oxidative Stress in Female Athletes Using Combined Oral Contraceptives [PDF]
Sports Medicine - Open, 2016 Background Oxidative stress in female athletes is understudied. We investigated oxidative stress in sportswomen of different disciplines according to combined oral contraceptive (OC) use and lifestyle/alimentary habits.
Buligan, Cinzia +3 more
core +2 more sources
Combined Oral Contraceptives As Victims of Drug Interactions. [PDF]
Drug Metab Dispos, 2023 Combined oral contraceptives (COCs) are widely used in women of reproductive age in the United States. Metabolism plays an important role in the elimination of estrogens and progestins contained in COCs. It is unavoidable that a woman using COCs may need
Li L, Yang X, Tran D, Seo SK, Lu Y.
europepmc +2 more sources
Review of the literature on combined oral contraceptives and cancer. [PDF]
Ecancermedicalscience, 2022 Millions of women have given preference to the use of combined oral contraceptives (COCs) since its introduction in the 1960s. Both oestrogens and progestogens can regulate proliferation and it is plausible these effects may contribute to carcinogenesis.
Kamani M, Akgor U, Gültekin M.
europepmc +2 more sources
Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk. [PDF]
Front Endocrinol (Lausanne), 2021 Many factors must be considered and discussed with women when initiating a contraceptive method and the risk of venous thromboembolism (VTE) is one of them.
Morimont L +4 more
europepmc +2 more sources
Combined oral contraceptives containing estradiol valerate vs ethinylestradiol on coagulation: A randomized clinical trial. [PDF]
Acta Obstet Gynecol Scand, 2022 Contraceptives containing ethinylestradiol (EE) induce changes in the coagulation system and are associated with a risk of venous thromboembolism. However, studies comparing the effects of combined oral contraceptives containing EE and low‐potency ...
Haverinen AH +9 more
europepmc +2 more sources
BJOG: an International Journal of Obstetrics and Gynaecology, 2022 To compare the risk of venous thromboembolism (VTE) among young women for nine combined oral contraceptives (COCs), including progestogens with an as yet unclear risk of VTE such as chlormadinone and nomegestrol, using COCs containing levonorgestrel with
T. Schink +3 more
semanticscholar +1 more source
BJOG: an International Journal of Obstetrics and Gynaecology, 2021 To investigate whether users of hormonal contraceptives (HCs) are at increased risk of depression compared with non‐users.
C. Lundin +7 more
semanticscholar +1 more source
Low dose combined oral contraceptives induced thrombotic anterior wall myocardial infarction: a case report. [PDF]
BMC Cardiovasc Disord, 2020 Background Combined oral contraceptive pills are associated with an established risk for venous thrombosis; however, their risk for arterial thrombosis remains uncertain, especially with the development of low dose new generations of combined oral ...
Rahhal A +5 more
europepmc +2 more sources